Roche affiche une très bonne performance au premier semestre 2019 – prévisions pour l’année révisées à la hausse

NEXT STORY
Curetis to Present at Solebury Trout European Biotech Investor Day in NYC
PREV STORY
Roxadustat China Phase 3 Trial for Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine (NEJM)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche’s TECENTRIQ in combination with chemotherapy helped people with previously-untreated extensive-stage small cell lung cancer live significantly longer compared to chemotherapy

IMpower133 is the first Phase III study with an immunotherapy-based combination to show improvement ...

author_avatar
NASDAQ Market News

XOMA Reports Fourth Quarter and Full Year 2018 Financial Results and Operating Highlights

author_avatar
NASDAQ Market News

First Brain Tumor Treated with Xoft IORT in the United States

author_avatar
NASDAQ Market News